Jove
Visualize
Contact Us

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study.

Brain sciences·2026
Same author

Chronic Pain and Posttraumatic Stress Among Patients in Substance Use Treatment: Protocol for NOR-APT, a Longitudinal Cohort Study.

JMIR research protocols·2025
Same author

Changes in quality of life during 52 weeks of extended-release naltrexone treatment, subsequent by a 1-year post-treatment period.

Drug and alcohol dependence·2025
Same author

Measuring Personal Recovery in a Sample of People with Opioid Use Disorder: Psychometric Properties of the Norwegian Version of the Questionnaire about the Process of Recovery.

European addiction research·2025
Same author

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study.

Addiction science & clinical practice·2025
Same author

Reward Sensitivity in Patients Receiving Opioid Agonist and Antagonist Treatment for Opioid Use Disorder: An Observational Study.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 10, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Neuropsychological functioning in late-life depression.

Gro Strømnes Dybedal1, Lars Tanum, Kjetil Sundet

  • 1Department of Geriatric Psychiatry, Diakonhjemmet Hospital Oslo, Norway.

Frontiers in Psychology
|July 3, 2013
PubMed
Summary

Late-life depression (LLD) patients show significant cognitive deficits, particularly in executive function, even after accounting for processing speed. These findings highlight executive dysfunction as a core neurocognitive issue in LLD.

Keywords:
executive functioninformation processing speedlate-life depressionmemoryneuropsychological

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement
10:37

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Published on: September 18, 2021

Related Experiment Videos

Last Updated: May 10, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement
10:37

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Published on: September 18, 2021

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Inconsistent findings exist regarding neurocognitive deficits in late-life depression (LLD).
  • Some studies suggest reduced processing speed underlies other cognitive deficits, while others indicate memory and executive function impairments.
  • This study aimed to characterize neuropsychological functioning in non-demented LLD patients.

Purpose of the Study:

  • To determine the specific neurocognitive characteristics of non-demented patients with late-life depression.
  • To compare the neuropsychological performance of LLD patients with healthy controls.

Main Methods:

  • A comprehensive neuropsychological battery was administered to 39 hospitalized LLD patients (aged 60+) and 18 healthy controls (HC).
  • LLD patients had a long-lasting, treatment-resistant depressive episode and no dementia.
  • Cognitive domains assessed included information processing speed, verbal/visuospatial memory, executive function, and language.

Main Results:

  • Nearly half of LLD patients exhibited clinically significant cognitive impairment in at least one domain.
  • LLD patients performed significantly worse than HC subjects in information processing speed and executive function.
  • Executive abilities were the most frequently impaired domain (39% of patients), persisting even after controlling for processing speed differences.

Conclusions:

  • Impaired executive function is a core neurocognitive deficit in late-life depression, independent of processing speed.
  • Executive function may encompass several distinct cognitive functions requiring further detailed investigation.
  • Additional research is needed to differentiate episode-related from persistent impairments in LLD.